Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients

mSphere (Feb 2021)

Affiliations

Skye R. S. Fishbein: ORCiD; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA
Tiffany Hink: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Kimberly A. Reske: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Candice Cass: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Emily Struttmann: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Zainab Hassan Iqbal: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Sondra Seiler: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Jennie H. Kwon: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA
Carey-Ann D. Burnham: ORCiD; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
Gautam Dantas: ORCiD; The Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA
Erik R. Dubberke: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA

Abstract

A gold standard diagnostic for Clostridioides difficile